Nalu Bio

For many, the holidays are a time for joy and celebration—but for the 30% of the global population suffering from chronic pain, they can also be a time of significant physical and emotional strain. Too often, opioids are the go-to solution, providing temporary relief but at a devastating cost: addiction, dependency, and lives lost. At Nalu Bio, we’re working to change that. By leveraging the body’s endocannabinoid system (ECS) and our AI-driven platform, we’re developing next-generation therapeutics that combine powerful analgesic and anti-inflammatory effects without the risks of addiction. Our innovative cannactives are designed to treat pain and inflammation, setting a new standard for effective and safe relief. Together, let’s imagine a future where chronic pain doesn’t define how people live their lives. Read how we’re paving the way for a future beyond opioids: #Innovation #PainRelief #ECS #Cannabinoids #AI #WellnessWednesday

As we navigate the season of indulgence, new research published by Springer Nature Current Diabetes Reports highlights the critical role of the endocannabinoid system (ECS) in regulating energy balance, food intake, and metabolism. The study reveals how ECS dysregulation contributes to obesity and metabolic disorders, providing fresh insights into these global health challenges. At Nalu Bio, we’re harnessing the power of this important system to develop prescription therapeutics and non-prescription supplements that solve the top health and wellness challenges—including weight management. Our AI-powered, pharmaceutical-quality supplements combine cannabinoids with bioactives to deliver effective, consistent, and safe results—all backed by third-party research to support women’s health at all stages. This tailored approach is particularly effective for women, as research shows that the ECS is more active in women’s bodies, especially as they age. Discover more about this study: https://lnkd.in/gMTatWBr Together, let’s innovate for a healthier, more balanced future! #Innovation #EndocannabinoidSystem #MetabolicHealth #Obesity #Wellness #HolidayEating #HealthTech

Last week, our co-founder and CEO, Caitlyn Krebs, had the privilege of joining an incredible panel of female founders at the Women Tech Meetup in San Francisco, hosted by the amazing Dasha Shunina. The conversation focused on aging and longevity—critical health challenges we’re all working to solve through innovation and collaboration. We’re especially grateful for the chance to share how Nalu Bio’s AI-enabled platform is accelerating the development of non-addictive pain therapeutics and wellness-focused supplements. Thank you to Dasha for hosting such a thoughtful event, and to all the inspiring panelists— Bobbie Kumar, MD MBA FAAFP, Alejandra Guillén, and Sophia Lugo—who are leading the way in health tech innovation. A special shoutout to our board member, Dondeena Bradley, who joined us at the event, for your guidance and support on this journey. Events like these remind us of the power of women in health tech to drive meaningful change. As we reflect on this Thanksgiving week, we’re filled with gratitude for this community of changemakers and their commitment to solving today’s top health challenges. Together, we’re redefining health and wellness for future generations. #WomenInTech #HealthTech #AgingAndLongevity #Gratitude #WellnessWednesday

Join us tomorrow evening (Tues. 11/19) in San Francisco for an engaging conversation about Aging & Longevity hosted by Forbes contributor Dasha Shunina. Our co-founder and CEO, Caitlyn Krebs will be sharing more about how our AI-enabled platform accelerates the development of prescription therapeutics and non-prescription supplements alongside an amazing lineup of health- and wellness- focused, female founders. There's still time to RSVP: https://lnkd.in/gq2cDZiS

This month, we had the opportunity to highlight Nalu Bio’s drug discovery journey at the BIO Investor Forum by the Biotechnology Innovation Organization, where our Co-Founder and CEO, Caitlyn Krebs, presented on unlocking the potential of the Endocannabinoid System (ECS). Caitlyn showcased our progress in tackling one of the most vital health challenges of our time—developing non-addictive pain therapeutics that provide sustained relief with the ambition to displace opioids. To further accelerate our drug discovery work, Nalu Bio has joined the NVIDIA Inception Program. With NVIDIA’s cutting-edge AI resources, we’ll elevate our drug discovery process, applying machine learning to identify and optimize safe, effective cannabinoid compounds targeted at chronic pain and other unmet health needs. Nalu Bio remains committed to delivering innovative, scalable solutions by combining AI-powered drug discovery with cannabinoid science. Here’s to taking the next steps in building a healthier future! #BIOInvestorForum #DrugDiscovery #PainManagement #NVIDIAInception #PharmaInnovation #OpioidAlternatives #AIinPharma #WellnessWednesday

Did you know that less than 1% of supplements are formulated specifically for women? This leaves a significant gap in addressing the unique health challenges they face—particularly stress, which affects women more severely due to hormonal changes. At Nalu Bio, we’re addressing this untapped opportunity by combining cannabinoids and bioactives, targeting the body’s Endocannabinoid System (ECS) to naturally reduce stress and promote resilience. We’re looking for partners to join us in bringing our products to women around the world, so we can transform the women’s health landscape through scientifically-backed solutions. Read our latest article to learn more. #WomensHealth #WellnessWednesday #StressRelief #ECS #WellnessInnovation #Partnership

We're #hiring a new Chief Science Officer (CSO) in San Francisco Bay Area. Apply today or share this post with your network.

We’re pleased to announce that Caitlyn Krebs, our Co-Founder and CEO, will be presenting at the BIO Investor Forum by the Biotechnology Innovation Organization in San Francisco this week. She’ll be discussing how Nalu Bio has identified a unique opportunity at the intersection of two emerging fields: The Endocannabinoid System (ECS)—the body’s natural balancing mechanism—and its application to essential health needs such as pain management. By combining our expertise in cannabinoid science with a pharmaceutical approach, we’re developing non-intoxicating molecules precisely tailored to unlock the untapped potential of the ECS and deliver scalable solutions that set a new standard for health and wellness. 🗓 When: October 16 at 1:30 p.m. 📍 Where: California Room, Fairmont Hotel, San Francisco Join us to learn more about our progress in tackling one of the most vital health challenges of our time—non-addictive pain therapeutics that provide sustained relief with the ambition to displace opioids. For more information about the event: https://lnkd.in/dZf3Myxg #BIOInvestorForum #DrugDiscovery #PainManagement #OpioidAlternatives #ChronicPain #PharmaAI

As highlighted in a recent article from Nutrition Insight, the rise of multifunctional supplements is paving the way for more efficient, synergistic health solutions. At Nalu Bio, we're taking this concept further by combining non-intoxicating cannabinoids with bioactives to create solutions specifically tailored for women’s health. Pairing cannabinoids with bioactives through predictive AI modeling allows us to maximize benefits for effective, consistent, and safe results. Only 1% of supplements are currently targeted to women. That’s why we’ll be taking our female-formulated supplements to #CONVERGENCE24 by the Council for Responsible Nutrition (CRN) this week (Oct 9-11) in Salt Lake City. Designed especially for women to support weight management, stress, sleep, and mobility, each formula is backed by third-party research, ensuring safety, efficacy, and targeted results for women at all stages of life. Who's attending? We’d love to connect! Learn more and register here: https://lnkd.in/etQqFa3N #CRN #FunctionalFood #DietarySupplements #WomenHealth #Innovation

The global stress management supplement market is projected to surpass $1B by 2034, according to NutraIngredients. With stress affecting millions worldwide, the demand for safe, effective solutions has never been higher. At Nalu Bio, we’re harnessing the power of the Endocannabinoid System (ECS) to create products that help people manage stress without the unwanted side effects. Our AI-driven formulations combine cannabinoids with concentrated vitamins, offering a natural way to restore balance and improve well-being. As the market for stress relief expands, Nalu Bio is at the forefront, developing innovative ECS-based solutions to meet this growing need. 🔗 Read more about the trends shaping the future of stress management here: https://lnkd.in/gvy2NJhT #StressManagement #ECS #HealthAndWellness #Cannabinoids #Innovation #Supplements